JAZZ PHARMACEUTICALS PLC (JAZZ) Forecast, Price Target & Analyst Ratings

NASDAQ:JAZZ • IE00B4Q5ZN47

Current stock price

186.95 USD
-1.32 (-0.7%)
At close:
186.95 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JAZZ PHARMACEUTICALS PLC (JAZZ).

Forecast Snapshot

Consensus Price Target

Price Target
$228.13
+ 22.02% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$4.63
Revenue Estimate
996.75M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$228.13
Upside
+ 22.02%
From current price of $186.95 to mean target of $228.13, Based on 23 analyst forecasts
Low
$189.88
Median
$230.01
High
$288.75

Price Target Revisions

1 Month
1.94%
3 Months
4.82%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for JAZZ. The average price target is 228.13 USD. This implies a price increase of 22.03% is expected in the next year compared to the current price of 186.95.
The average price target has been revised upward by 4.82% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

JAZZ Current Analyst RatingJAZZ Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

JAZZ Historical Analyst RatingsJAZZ Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
85.22%
JAZZ was analyzed by 23 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about JAZZ.
In the previous month the buy percentage consensus was at a similar level.
JAZZ was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-19Piper SandlerMaintains Overweight -> Overweight
2026-02-27BarclaysInitiate Overweight
2026-02-25RBC CapitalMaintains Outperform -> Outperform
2026-02-25Wells FargoMaintains Overweight -> Overweight
2026-02-25B of A SecuritiesMaintains Buy -> Buy
2026-02-25Morgan StanleyMaintains Overweight -> Overweight
2026-01-12NeedhamMaintains Buy -> Buy
2026-01-12Truist SecuritiesMaintains Buy -> Buy
2025-12-10Piper SandlerReiterate Overweight -> Overweight
2025-11-24UBSDowngrade Buy -> Neutral
2025-11-18Wells FargoMaintains Overweight -> Overweight
2025-11-18BairdMaintains Outperform -> Outperform
2025-11-18B of A SecuritiesMaintains Buy -> Buy
2025-11-17Morgan StanleyMaintains Overweight -> Overweight
2025-11-06RBC CapitalMaintains Outperform -> Outperform
2025-10-27JP MorganMaintains Overweight -> Overweight
2025-10-20Morgan StanleyMaintains Overweight -> Overweight
2025-09-24Morgan StanleyMaintains Overweight -> Overweight
2025-08-29Goldman SachsMaintains Buy -> Buy
2025-08-28NeedhamReiterate Buy -> Buy
2025-08-28RBC CapitalMaintains Outperform -> Outperform
2025-08-28Truist SecuritiesMaintains Buy -> Buy
2025-08-28Morgan StanleyMaintains Overweight -> Overweight
2025-08-20NeedhamReiterate Buy -> Buy
2025-08-06Morgan StanleyMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$4.63
Revenue Estimate
996.75M
Revenue Q2Q
11.02%
EPS Q2Q
175.54%
Number of Analysts
17

Next Earnings Revisions

Revenue (1 Month)
-0.56%
Revenue (3 Months)
-0.86%
EPS (1 Month)
6.15%
EPS (3 Months)
-3.62%

Next Earnings Summary

JAZZ is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 4.63 USD and the consensus revenue estimate is 996.75M USD.
The next earnings revenue estimate has been revised downward by 0.86% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
JAZZ revenue by date.JAZZ revenue by date.
3.834B
4.78%		4.069B
6.12%		4.268B
4.88%		4.529B
6.13%		4.88B
7.75%		5.288B
8.36%		5.831B
10.27%		6.108B
4.75%		5.854B
-4.16%		6.117B
4.49%		6.214B
1.59%
EBITDA
YoY % growth
JAZZ ebitda by date.JAZZ ebitda by date.
1.317B
78.37%		1.387B
5.29%		1.214B
-12.46%		2.155B
77.52%		2.135B
-0.93%		2.397B
12.27%		2.503B
4.42%		2.699B
7.83%		2.78B
3.00%		2.971B
6.87%		3.06B
3.00%
EBIT
YoY % growth
JAZZ ebit by date.JAZZ ebit by date.
678.38M
522.94%		726.63M
7.11%		517.622M
-28.76%		1.993B
285.03%		2.093B
5.02%		2.186B
4.44%		2.523B
15.42%		2.576B
2.10%		2.129B
-17.35%		2.4B
12.73%		2.22B
-7.50%
Operating Margin
JAZZ operating margin by date.JAZZ operating margin by date.
17.69%17.86%12.13%44.01%42.89%41.34%43.27%42.17%36.37%39.23%35.73%
EPS
YoY % growth
JAZZ eps by date.JAZZ eps by date.
18.32
39.53%		21.19
15.67%		8.20
-61.30%		24.93
204.02%		25.26
1.34%		27.15
7.48%		30.91
13.83%		32.62
5.53%		24.78
-24.04%		27.11
9.42%		23.38
-13.76%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		4.63
175.54%		6.03
173.07%		6.35
-21.87%		7.20
8.41%		4.80
3.78%		6.23
3.42%		7.02
10.48%		7.46
3.69%
Revenue
Q2Q % growth		996.75M
11.02%		1.121B
7.20%		1.177B
4.52%		1.231B
2.76%		1.05B
5.34%		1.206B
7.58%		1.277B
8.50%		1.351B
9.75%
EBITDA
Q2Q % growth		400.58M
267.57%		501.01M
-10.19%		540.27M
-12.46%		624.45M
-34.33%		N/AN/AN/AN/A
EBIT
Q2Q % growth		391.45M
800.37%		490.96M
124.21%		520.33M
420.28%		601.97M
136.50%		428.5M
9.46%		526.73M
7.29%		576.81M
10.85%		621.79M
3.29%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

JAZZ Yearly Revenue VS EstimatesJAZZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
JAZZ Yearly EPS VS EstimatesJAZZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
49.05%
EPS Next 5 Year
31.81%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.93%
Revenue Next 5 Year
7.16%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
53.46%
EBIT Next 5 Year
32.40%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

JAZZ PHARMACEUTICALS PLC / JAZZ Forecast FAQ

What do analysts expect the price target to be for JAZZ PHARMACEUTICALS PLC (JAZZ)?

23 analysts have analysed JAZZ and the average price target is 228.13 USD. This implies a price increase of 22.03% is expected in the next year compared to the current price of 186.95.

Can you provide the upcoming earnings date for JAZZ PHARMACEUTICALS PLC?

JAZZ PHARMACEUTICALS PLC (JAZZ) will report earnings on 2026-05-04.

What are the consensus estimates for JAZZ stock next earnings?

The consensus EPS estimate for the next earnings of JAZZ PHARMACEUTICALS PLC (JAZZ) is 4.63 USD and the consensus revenue estimate is 996.75M USD.

What is the expected long term growth rate for JAZZ PHARMACEUTICALS PLC (JAZZ)?

The expected long term growth rate for JAZZ PHARMACEUTICALS PLC (JAZZ) is 6.93%.